UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document

Veterinary & comparative oncology, 2010-03, Vol.8 (1), p.28-37

2010

Volltextzugriff (PDF)

Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma

Veterinary & comparative oncology, 2018-03, Vol.16 (1), p.E23-E29

2018

Volltextzugriff (PDF)

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document

Veterinary & comparative oncology, 2015-09, Vol.13 (3), p.176-183

2015

Volltextzugriff (PDF)

Canine Osteosarcoma: A Naturally Occurring Disease to Inform Pediatric Oncology

ILAR journal, 2014, Vol.55 (1), p.69-85

2014

Volltextzugriff (PDF)

Non‐immunosuppressive FTY720‐derivative OSU‐2S mediates reactive oxygen species‐mediated cytotoxicity in canine B‐cell lymphoma

Veterinary & comparative oncology, 2017-09, Vol.15 (3), p.1115-1118

2017

Volltextzugriff (PDF)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

Journal of veterinary internal medicine, 2018-01, Vol.32 (1), p.394-405

2018

Volltextzugriff (PDF)

Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing

Journal of immunological methods, 2007-08, Vol.325 (1), p.114-126

2007

Volltextzugriff (PDF)

Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone‐invasive oral squamous cell carcinoma

Veterinary & comparative oncology, 2015-09, Vol.13 (3), p.203-217

2015

Volltextzugriff (PDF)

Mitotic index is predictive for survival for canine cutaneous mast cell tumors

Veterinary pathology, 2007-05, Vol.44 (3), p.335-341

2007

Volltextzugriff (PDF)

Multicenter Prospective Trial of Hypofractionated Radiation Treatment, Toceranib, and Prednisone for Measurable Canine Mast Cell Tumors

Journal of veterinary internal medicine, 2012-01, Vol.26 (1), p.135-141

2012

Volltextzugriff (PDF)

Identification of a novel germline MET mutation in dogs

Animal genetics, 2006-06, Vol.37 (3), p.248-252

2006

Volltextzugriff (PDF)

Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial

Clinical cancer research, 1995-10, Vol.1 (10), p.1165-1170

1995

Volltextzugriff (PDF)

Expression of stem cell factor receptor (c- kit) by the malignant mast cells from spontaneous canine mast cell tumours

Journal of comparative pathology, 1996-11, Vol.115 (4), p.399-414

1996

Volltextzugriff (PDF)

Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis

Immunity (Cambridge, Mass.), 1998-05, Vol.8 (5), p.615-623

1998

Volltextzugriff (PDF)

Met interacts with EGFR and Ron in canine osteosarcoma

Veterinary & comparative oncology, 2013-06, Vol.11 (2), p.124-139

2013

Volltextzugriff (PDF)

Functional Responses and Costimulator Dependence of Memory CD4+ T Cells

The Journal of immunology (1950), 2000-01, Vol.164 (1), p.265-272

2000

Volltextzugriff (PDF)

Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma

Experimental hematology, 1996-06, Vol.24 (7), p.807

1996

Volltextzugriff (PDF)

Phase II Clinical Trial of Vinorelbine in Dogs with Cutaneous Mast Cell Tumors

Journal of veterinary internal medicine, 2008-03, Vol.22 (2), p.388-393

2008

Volltextzugriff (PDF)

The Roles of CD28 and CD40 Ligand in T Cell Activation and Tolerance

The Journal of immunology (1950), 2000-05, Vol.164 (9), p.4465-4470

2000

Volltextzugriff (PDF)

Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c- kit

Experimental hematology, 1999-04, Vol.27 (4), p.689-697

1999

Volltextzugriff (PDF)

Treatment of canine mast cell tumors with CCNU (lomustine)

Journal of veterinary internal medicine, 1999-11, Vol.13 (6), p.601-605

1999

Volltextzugriff (PDF)

Lomustine (CCNU) for the Treatment of Resistant Lymphoma in Dogs

Journal of veterinary internal medicine, 1999-09, Vol.13 (5), p.395-398

1999

Volltextzugriff (PDF)

Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)

Veterinary & comparative oncology, 2009-12, Vol.7 (4), p.244-255

2009

Volltextzugriff (PDF)

A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma

Veterinary & comparative oncology, 2007-09, Vol.5 (3), p.177-196

2007

Volltextzugriff (PDF)

TH-CD-202-09: Free-Breathing Proton MRI Functional Lung Avoidance Maps to Guide Radiation Therapy

Medical physics (Lancaster), 2016-06, Vol.43 (6), p.3878-3878

2016

Volltextzugriff (PDF)

1 – 25 von 5.646

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.672)
Mit Volltextzugriff
(4.630)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.859)
Life Sciences & Biomedicine
(1.901)
Humans
(1.281)
Male
(783)
Female
(744)
Biological And Medical Sciences
(741)
Animals
(701)
Physical Sciences
(700)
Physics
(571)
Medical Sciences
(490)
Adult
(446)
Middle Aged
(360)
Technology
(301)
Fundamental And Applied Biological Sciences. Psychology
(285)
Aged
(231)
Mice
(204)
Biochemistry & Molecular Biology
(190)
Risk Factors
(186)
Oncology
(171)
Child
(167)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document

Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document

Canine Osteosarcoma: A Naturally Occurring Disease to Inform Pediatric Oncology

Non‐immunosuppressive FTY720‐derivative OSU‐2S mediates reactive oxygen species‐mediated cytotoxicity in canine B‐cell lymphoma

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing

Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone‐invasive oral squamous cell carcinoma

Mitotic index is predictive for survival for canine cutaneous mast cell tumors

Multicenter Prospective Trial of Hypofractionated Radiation Treatment, Toceranib, and Prednisone for Measurable Canine Mast Cell Tumors

Identification of a novel germline MET mutation in dogs

Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial

Expression of stem cell factor receptor (c- kit) by the malignant mast cells from spontaneous canine mast cell tumours

Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis

Met interacts with EGFR and Ron in canine osteosarcoma

Functional Responses and Costimulator Dependence of Memory CD4+ T Cells

Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma

Phase II Clinical Trial of Vinorelbine in Dogs with Cutaneous Mast Cell Tumors

The Roles of CD28 and CD40 Ligand in T Cell Activation and Tolerance

Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c- kit

Treatment of canine mast cell tumors with CCNU (lomustine)

Lomustine (CCNU) for the Treatment of Resistant Lymphoma in Dogs

Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)

A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma

TH-CD-202-09: Free-Breathing Proton MRI Functional Lung Avoidance Maps to Guide Radiation Therapy

Suchergebnisse filtern